Suppression by ergocornine and iproniazid of carcinogen-induced mammary tumors in rats; effects on serum and pituitary prolactin levels.
D000818:Animals; D001551:Benz(a)Anthracenes / Q000037:antagonists & inhibitors*; D004298:Dopamine / Q000494:pharmacology; D004873:Ergolines / Q000494:pharmacology*; D005260:Female; D007490:Iproniazid / Q000494:pharmacology*; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced*; D009929:Organ Size; D010902:Pituitary Gland / Q000032:analysis; D011388:Prolactin / Q000097:blood*; D011863:Radioimmunoassay; D051381:Rats
D001551:Benz(a)Anthracenes; D004873:Ergolines; D011388:Prolactin; D007490:Iproniazid; D004298:Dopamine